Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 614 | 613 | 87 | 84 | 115 |
| Accounts payable and accrued liabilities | 211 | 645 | 726 | N/A | N/A |
| Other Working Capital | -262 | 1,888 | 673 | 544 | -135 |
| Other Operating Activity | -34,454 | -24,704 | -24,693 | -10,919 | -12,204 |
| Operating Cash Flow | $-33,891 | $-21,558 | $-23,207 | $-10,291 | $-12,225 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79 | -102 | -329 | -13 | -4 |
| Purchase Of Investment | N/A | -17,268 | N/A | -798 | N/A |
| Sale Of Investment | 12,707 | N/A | 341 | N/A | 6,134 |
| Other Investing Activity | 0 | 0 | 0 | 68 | 78 |
| Investing Cash Flow | $12,628 | $-17,370 | $12 | $-743 | $6,209 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 58,402 | 93,167 | 25,720 | 13,394 | 5,618 |
| Other Financing Activity | 405 | 10,281 | 2,151 | 324 | 0 |
| Financing Cash Flow | $58,807 | $103,448 | $27,871 | $13,718 | $5,618 |
| Exchange Rate Effect | 7 | 23 | -8 | 7 | -227 |
| Beginning Cash Position | 79,842 | 15,299 | 10,631 | 7,940 | 8,558 |
| End Cash Position | 117,393 | 79,842 | 15,299 | 10,631 | 7,932 |
| Net Cash Flow | $37,544 | $64,520 | $4,676 | $2,684 | $-399 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,891 | -21,558 | -23,207 | -10,291 | -12,225 |
| Capital Expenditure | -79 | -102 | -329 | -13 | -4 |
| Free Cash Flow | -33,970 | -21,660 | -23,536 | -10,304 | -12,229 |